Emagin Corporation (EMAN) saw its loss widen to $3.47 million, or $0.11 a share for the quarter ended Dec. 31, 2016. In the previous year period, the company reported a loss of $2.12 million, or $0.08 a share. Revenue during the quarter plunged 32.11 percent to $4.56 million from $6.71 million in the previous year period. Gross margin for the quarter contracted 271 basis points over the previous year period to 10.75 percent. Operating margin for the quarter stood at negative 82.73 percent as compared to a negative 31.32 percent for the previous year period.
Operating loss for the quarter was $3.77 million, compared with an operating loss of $2.10 million in the previous year period.
However, the adjusted EBITDA for the quarter stood at negative $3.23 million compared to negative $1.56 million in the prior year second quarter. At the same time, adjusted EBITDA margin stood at negative 70.82 percent for the quarter compared to negative 23.26 percent in the last year period.
“I am pleased to announce that we recently signed an additional, multi-million dollar agreement with another major Tier 1 consumer electronics company. We now have in place multiple agreements with commercial partners for next generation prototype products for consumer HMDs and expect a considerable boost to 2017 revenue from our commercial efforts, including approximately $1.5 million that we expect to recognize in the first quarter of 2017. As we continue to enhance our technological advantage through direct patterning, I believe that we are gaining the recognition we deserve for having the most comprehensive suite of high performance OLED microdisplays in the market today,” commented Andrew Sculley, president and chief executive officer.
Working capital declinesEmagin Corporation has witnessed a decline in the working capital over the last year. It stood at $11.20 million as at Dec. 31, 2016, down 19.66 percent or $2.74 million from $13.94 million on Dec. 31, 2015. Current ratio was at 2.66 as on Dec. 31, 2016, down from 3.98 on Dec. 31, 2015.
Disclaimer: Please note that this is an auto-generated article. IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website. For queries contact: editor@irisindia.net